Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Triple negative breast cancer (TNBC) is a heterogeneous disease with distinct molecular subtypes that differentially respond to chemotherapy and targeted agents. The purpose of this study is to explore the clinical relevance of Lehmann TNBC subtypes by identifying any differences in response to neoa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Santonja, Angela, Sánchez-Muñoz, Alfonso, Lluch, Ana, Chica-Parrado, Maria Rosario, Albanell, Joan, Chacón, José Ignacio, Antolín, Silvia, Jerez, José Manuel, de la Haba, Juan, de Luque, Vanessa, Fernández-De Sousa, Cristina Elisabeth, Vicioso, Luis, Plata, Yéssica, Ramírez-Tortosa, César Luis, Álvarez, Martina, Llácer, Casilda, Zarcos-Pedrinaci, Irene, Carrasco, Eva, Caballero, Rosalía, Martín, Miguel, Alba, Emilio
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995183/
https://ncbi.nlm.nih.gov/pubmed/29899867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25413
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires